Across TCGA pan-cancer cohorts, LINC00326 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC00326 data layer compared with 18 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC00326 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00326 expression acts as an unfavorable survival marker.
UCEC and BRCA are the cancer types where LINC00326 Mutation most reproducibly stratifies survival.